Young-Hwa Chung Selected Research

Young-Hwa Chung Research Topics

Disease

53	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2002
42	Neoplasms (Cancer) 12/2022 - 01/2002
21	Chronic Hepatitis B 08/2014 - 05/2003
13	Infections 01/2016 - 05/2002
12	Fibrosis (Cirrhosis) 11/2018 - 12/2002
9	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2013
7	Colonic Neoplasms (Colon Cancer) 06/2019 - 04/2009
6	Lymphoma (Lymphomas) 01/2016 - 06/2004
6	Liver Diseases (Liver Disease) 11/2011 - 10/2005
5	Carcinogenesis 01/2020 - 04/2009
5	Neoplasm Metastasis (Metastasis) 11/2016 - 08/2009
5	Hepatitis B 01/2016 - 01/2010
5	Liver Neoplasms (Liver Cancer) 12/2015 - 06/2011
5	Hepatitis 06/2013 - 03/2002
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2002
4	Thrombosis (Thrombus) 03/2015 - 11/2002
4	Chronic Hepatitis (Chronic Active Hepatitis) 12/2010 - 05/2003
3	Hepatic Encephalopathy 01/2020 - 12/2002
3	Non-alcoholic Fatty Liver Disease 11/2015 - 05/2010
3	End Stage Liver Disease 08/2015 - 10/2005
3	Hypoxia (Hypoxemia) 05/2015 - 03/2008
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2015 - 02/2011
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2014 - 06/2011
3	Disease Progression 10/2012 - 12/2006
2	Carcinoma (Carcinomatosis) 02/2022 - 11/2014
2	Hemorrhage 01/2022 - 12/2002
2	Esophageal and Gastric Varices (Esophageal Varices) 01/2022 - 12/2002
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 11/2012
2	Virus Diseases (Viral Diseases) 05/2015 - 12/2010
2	Inflammation (Inflammations) 01/2014 - 12/2007
2	Adenocarcinoma 06/2012 - 02/2011
2	Melanoma (Melanoma, Malignant) 04/2011 - 09/2010
2	Reoviridae Infections 04/2010 - 09/2009
2	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2002 - 05/2002

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2022 - 05/2002
14	Lamivudine (Epivir)FDA Link 01/2016 - 03/2002
11	CateninsIBA 01/2020 - 08/2009
9	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 05/2003
9	Hepatitis B e AntigensIBA 08/2014 - 02/2004
8	Alanine Transaminase (SGPT)IBA 11/2022 - 02/2004
8	Antiviral Agents (Antivirals)IBA 01/2016 - 05/2006
7	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2013 - 01/2002
6	Sorafenib (BAY 43-9006)FDA Link 07/2020 - 01/2013
5	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 07/2012
5	CytokinesIBA 01/2018 - 05/2002
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 05/2003
5	Cyclin D1IBA 05/2017 - 08/2009
5	Neoplasm Antigens (Tumor Antigens)IBA 12/2014 - 03/2008
5	InterferonsIBA 06/2013 - 05/2003
5	clevudineIBA 03/2011 - 05/2006
4	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2012
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2014
4	entecavir FDA Link 01/2016 - 10/2009
4	Fetal Proteins (Fetoprotein)IBA 12/2015 - 11/2011
4	Oncogene Proteins (Oncogene Protein)IBA 07/2014 - 02/2007
4	Sirtuin 1IBA 01/2014 - 06/2012
4	Ethiodized Oil (Ethiodol)FDA Link 06/2013 - 01/2002
4	adefovir dipivoxil (Hepsera)FDA Link 02/2012 - 10/2005
4	lipoarabinomannan (LAM)IBA 02/2012 - 12/2004
4	adefovirIBA 09/2010 - 06/2006
3	Messenger RNA (mRNA)IBA 02/2022 - 01/2002
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	TCF Transcription FactorsIBA 05/2017 - 06/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015 - 04/2010
3	Etoposide (VP 16)FDA LinkGeneric 03/2015 - 01/2014
3	beta CateninIBA 09/2009 - 04/2009
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2009 - 01/2002
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2018
2	Serum AlbuminIBA 10/2021 - 12/2015
2	Phosphotransferases (Kinase)IBA 01/2020 - 11/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 12/2017
2	3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2- dimethyl- 8- oxo- 3,4- dihydro- 2H,8H- pyrano(3,2- g)chromen- 3- yl- esterIBA 01/2019 - 01/2012
2	xanthoneIBA 01/2019 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 12/2018 - 03/2002
2	A Kinase Anchor ProteinsIBA 11/2018 - 01/2018
2	CholesterolIBA 01/2018 - 08/2012
2	Transcription Factors (Transcription Factor)IBA 05/2015 - 04/2011
2	Pemetrexed (MTA)FDA Link 12/2014 - 08/2009
2	hepatitis B virus X proteinIBA 07/2014 - 12/2012
2	ResveratrolIBA 07/2012 - 06/2012
2	HLA-DRB1 Chains (HLA DRB1)IBA 05/2012 - 01/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 05/2012 - 01/2011
2	AntigensIBA 03/2012 - 03/2011
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2012 - 02/2009
2	ElafinIBA 04/2011 - 09/2010
2	Immunoglobulins (Immunoglobulin)IBA 04/2011 - 01/2010
2	Ribavirin (Virazole)FDA LinkGeneric 06/2010 - 12/2007
2	Serine (L-Serine)FDA Link 08/2009 - 10/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2009 - 08/2003
2	Tamoxifen FDA LinkGeneric 02/2009 - 03/2003
1	Pyruvate KinaseIBA 02/2022

Therapy/Procedure

29	Therapeutics 01/2018 - 03/2002
7	Liver Transplantation 01/2020 - 12/2007
6	Radiotherapy 01/2018 - 06/2007
5	Drug Therapy (Chemotherapy) 01/2018 - 04/2010
4	Hepatectomy 01/2020 - 03/2010
2	Transplantation 01/2019 - 01/2013
2	Radiofrequency Ablation 12/2015 - 12/2013
2	Aftercare (After-Treatment) 05/2015 - 11/2002
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 03/2008 - 12/2002